Linkedin R4 Board Question Changes Everything

Length: ~1,100 words

There is one question that changes the CMO's relationship with the board permanently, when the CMO can answer it correctly.

"How much revenue did marketing generate last quarter?"

Not "how many leads." Not "what was the CPL." Not "what was the return on ad spend." Those are metrics that describe marketing activity. The board is asking about marketing's contribution to the business outcome — in rupees.

Most CMOs cannot answer this question. Not because the revenue is not there — in most healthcare organisations, marketing is clearly driving a significant proportion of revenue. But because the infrastructure to attribute that revenue to specific marketing activities does not exist.

The marketing P&L is missing.

What a marketing P&L is (and is not)

A marketing P&L is not an ROAS report. Return on Ad Spend measures media efficiency — how much revenue was generated for each rupee of media spend. It is a useful operational metric. It is not a business P&L.

A marketing P&L shows: total marketing investment (media + agency + technology) in the period → attributed consultations by channel → procedure revenue attributable to those consultations → marketing contribution to total hospital revenue → CPQL by specialty.

When a CMO can show a CFO this number — "marketing generated ₹X crore in procedure revenue last quarter, here is the breakdown by specialty and channel" — two things happen.

First, the CFO's relationship with the marketing budget changes. It stops being a cost centre line item and becomes an investment with a measurable return. Defending the marketing budget at the annual planning meeting becomes a conversation about revenue, not about awareness or lead volume.

Second, the CMO's relationship with the board changes. Every quarter, the CMO walks in with a specific number. The trend is trackable. The investment thesis is visible. The question "what did marketing generate?" has an answer.

Why most hospital CMOs cannot produce this number today

The infrastructure gap that prevents most hospital CMOs from answering the board's question has three components:

Server-side attribution: Standard pixel tracking in 2026 misses 35–42% of conversions in iOS-heavy urban markets. Marketing attribution built on pixel-only tracking is systematically incomplete. The fix: Beacon CAPI — a 3-week deployment that closes the tracking gap.

Offline conversion import: Even where clicks are tracked, the chain breaks between consultation booking and procedure revenue. Beacon's offline conversion import connects the CRM's consultation attendance events to Google and Meta's algorithms — enabling full-funnel attribution from ad impression to attended consultation to procedure code in the HIS.

Board-ready reporting: Even where the data exists, most healthcare organisations do not have a reporting format that translates CPQL data into the language the board reads. Agency OS's Gemini-powered monthly narrative translates the data into: "Marketing generated ₹X crore in attributed revenue last quarter, driven primarily by [specialty], at a CPQL of ₹X — Y% below market median. Three strategic recommendations for next quarter: [1, 2, 3]."

That is the report the CMO hands to the CFO.

The quarter that changes the relationship

The quarter a CMO produces their first board-ready marketing P&L is a milestone. Not because the number is perfect — the first attribution report is rarely comprehensive. But because it exists. It is directional. It is improvable.

"We attributed 63% of new-patient consultation revenue to marketing this quarter. Our target is 80% in two quarters. Here is what we are building to close the remaining attribution gap." That is a progress narrative. Boards respond to progress narratives.

The CMO who cannot produce any revenue attribution number, for the third board meeting in a row, is in a different position entirely.

One of ICG's Co-Founders once described the transition this way: "The marketing P&L is not the end. It is the beginning. Once you have a marketing P&L, every conversation with the board, every budget request, every new channel decision is anchored in a shared reality. Before it, every conversation is defended with anecdote and impression."

Build the marketing P&L. Answer the board question.

→ Healthcare Marketing P&L: How to Build One the CFO Will Believe

ABHASH'S ARTICLES (4)